FIGURE 1.

ZHX3 has been identified as an oncogenic factor in UCB and is associated with poor DFS and OS in patients with UCB. A, The ZHX3 gene either showed gain or amplification in patients with UCB from the TCGA database. B, Gain or amplification of ZHX3 was positively correlated with the high level of ZHX3 mRNA expression. C, D, The copy number of ZHX3 was positively correlated with worse clinical parameters. E, F, Prognostic significance of ZHX3 in 408 patients with UCB assessed by Kaplan‐Meier analysis